These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 32015333)
1. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma. Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333 [TBL] [Abstract][Full Text] [Related]
2. A functional loop between YTH domain family protein YTHDF3 mediated m Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428 [TBL] [Abstract][Full Text] [Related]
4. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression. Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215 [TBL] [Abstract][Full Text] [Related]
5. A20 inhibits the motility of HCC cells induced by TNF-α. Wang X; Ma C; Zong Z; Xiao Y; Li N; Guo C; Zhang L; Shi Y Oncotarget; 2016 Mar; 7(12):14742-54. PubMed ID: 26909601 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
7. EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL. Pan M; Luo M; Liu L; Chen Y; Cheng Z; Wang K; Huang L; Tang N; Qiu J; Huang A; Xia J J Exp Clin Cancer Res; 2024 Jan; 43(1):35. PubMed ID: 38287371 [TBL] [Abstract][Full Text] [Related]
8. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma. Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057 [TBL] [Abstract][Full Text] [Related]
9. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma. Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912 [TBL] [Abstract][Full Text] [Related]
10. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
11. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761 [TBL] [Abstract][Full Text] [Related]
12. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex. Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907 [TBL] [Abstract][Full Text] [Related]
13. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing. Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263 [No Abstract] [Full Text] [Related]
14. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151 [TBL] [Abstract][Full Text] [Related]
16. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma. Yi PS; Shu Y; Bi WX; Zheng XB; Feng WJ; He LY; Li JS J Cell Physiol; 2019 Dec; 234(12):21479-21484. PubMed ID: 31134613 [TBL] [Abstract][Full Text] [Related]
18. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523 [TBL] [Abstract][Full Text] [Related]
19. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells. Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758 [TBL] [Abstract][Full Text] [Related]
20. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37. Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]